Wilding JPH, Kwan AYM, Maldonado JM, Wang H, Rasouli N (2022) Tirzepatide induces weight loss in patients with type 2 diabetes regardless of baseline BMI: a post hoc analysis of SURPASS-1 through SURPASS-5 studies
Initial 3 week subscription and 4 weeks of medication from $149 plus tax and $349 per month plus tax for 12 week subscription thereafter
In the first four weeks, they can: With GLP-1s, we start you on a very low dose to get your body used to the medication
JAMA Intern Med 176 , 14741481 (2016)
For GLP-1s for overweight adults, the FDA label says they should have at least one additional, unspecified health risk
Studies have found that higher doses can further reduce glycosylated hemoglobin and body weight, and the safety is similar to low doses